Introduction
Depression in people living with chronic medical illnesses has a higher prevalence than in medically healthy individuals (Moussavi et al. 2007) , and is associated with worse self-care behaviors (DiMatteo et al. 2000; Gonzalez et al. 2008 Gonzalez et al. , 2011 . In people living with HIV/AIDS (PLWHA), rates are as high as 37% in various studies (Asch et al. 2003; Atkinson and Grant 1994; Bing et al. 2001; Ciesla and Roberts 2001; Dew et al. 1997) . Depression in PLWHA is associated with poorer disease course and worse health risk behaviors (Safren et al. 2009 ). For example, PLWHA with depression exhibit a more rapid decline in CD4 cells, faster HIV viral load increase, faster progression to AIDS (Horberg et al. 2008; Ironson et al. 2005; Leserman 2008 ), as well as increased substance use (Pence et al. 2006; Tegger et al. 2008 ), more risky sexual behavior (Kelly and Amirkhanian 2003; O'Cleirigh et al. 2013; Shrier et al. 2001) , and, importantly, poor adherence to antiretroviral medication (Gonzalez et al. 2011; Uthman et al. 2014) .
Fortunately, depression in PLWHA is amenable to change via psychotherapeutic interventions, especially cognitive behavioral therapies (Brown et al. 2016; see; Olatunji et al. 2006 for a review). One evidenced-based approach, cognitive-behavioral therapy for adherence and depression (CBT-AD), has a growing evidence base in individuals with chronic illness, such as in PLWHA (Brown et al. 2016; Safren et al. 2009 Safren et al. , 2012 Safren et al. , 2016 Simoni et al. 2013) Abstract Depression in people living with HIV/AIDS (PLWHA) is highly prevalent and related to worse adherence to antiretroviral therapy, but is amenable to change via CBT. Cognitive-behavioral therapy for adherence and depression (CBT-AD) specifically addresses negative automatic thoughts (ATs) as one component of the treatment. There is little research on the temporal nature of the relation between ATs and depression. HIV-positive adults with depression (N = 240) were randomized to CBT-AD, information/supportive psychotherapy for adherence and depression (ISP-AD), or one session of adherence counseling alone (ETAU). ATs were self-reported (Automatic Thoughts Questionnaire; ATQ) and depression was assessed by blinded interview (Montgomery-Asberg Depression Rating Scale; MADRS) at baseline, and 4-, 8-, and 12-months. We performed autoregressive cross-lagged panel models. Broadly, decreases in ATs were followed by decreases in depression, but decreases in depression were not followed by decreases in ATs. In CBT-AD, decreases in ATs were followed by decreases in depression, and vice versa. However, in the ISP group, while depression and ATs both significantly influenced each other, not all relations were in the direction expected. This study adds to the evidence base for cognitive interventions to decrease and diabetes , despite its challenges in application (Simoni et al. 2011) . CBT-AD contains interventions that specifically address medication adherence and, for depression, modules for behavioral activation, cognitive restructuring with a particular focus on negative automatic thoughts (ATs), problem-solving, and relaxation training.
Negative ATs are repetitive thoughts that contain themes of personal loss or failure (Hollon and Kendall 1980; Smith and Alloy 2009) . Previous research has shown that ATs and depressive symptoms are correlated, and posit that they likely influence each other to maintain depression (Kwon and Oei 1992; Moorey 2010) . One study has shown that ATs decreased pre to post following an inpatient CBT intervention for depression (Forsyth et al. 2010) . Another study did attempt to measure the relation between dysfunctional attitudes, automatic thoughts, and depression, though only tested structural equation models that had automatic thoughts predicting depression (Kwon and Oei 2003) . Additionally, one study found that reductions in ATs and dysfunctional beliefs were significantly associated with decreased depressive symptoms in the course of a cognitive behavioral therapy intervention, naming both as a possible mechanism of action in CBT interventions (Furlong and Oei 2002) .
However, there is no research to our knowledge that has empirically examined the temporal nature of the relation of ATs and depressive symptoms. Importantly, no research to our knowledge has examined this temporality in the context of interventions to alleviate depression, which may speak to an important mechanism of CBT and the CBT-AD intervention. Also, previous research on depression and automatic thoughts has been limited in methodology and statistical approaches, often using cross-sectional datasets or statistical approaches that compare data at the same time point, or using techniques that limit statements of temporality. This study aims to determine the temporal relation between ATs and depression, in the context of the CBT-AD treatment, utilizing appropriate methodological and statistical approaches (i.e., cross-lagged panel analysis).
While this is an exploratory study, we hypothesized that, based on previous literature (Kwon and Oei 1992; Moorey 2010) in all three groups, depression and ATs will be positively related, and that ATs will predict depression more so than depression predicts ATs (Kwon and Oei 2003) .
Method

Design and Procedures
The parent study was a 12-month, 3-arm randomized controlled efficacy trial (Safren et al. 2016) . The arms were (1) CBT-AD, (2) ISP-AD and (3) ETAU, as described below. Major assessments were conducted at baseline, 4 months (post-treatment / acute outcome, after all of the intervention sessions ended), 8 months, and 12 months. Visits took place at one of three HIV clinics in New England. All procedures were reviewed and approved by the respective Institutional Review Boards: Massachusetts General Hospital, Fenway Health, and The Miriam Hospital.
The parent study focused on CBT-AD versus ETAU and ISP-AD for depression and medication adherence in people living with HIV/AIDS (Safren et al. 2016) . The parent study found that patients who were assigned to CBT-AD had greater improvements in adherence than did patients who had ETAU after treatment. No significant differences in adherence or depression were noted between CBT-AD and ISP-AD.
Interventions
ETAU
All participants, regardless of treatment assignment, had three enhancements to their usual care: (1) a single-session adherence counseling intervention, Life-Steps (Safren et al. 1999) , (2) a provider letter sent after the baseline visit and, (3) at follow-up visits, referrals for depression treatment if clinically indicated.
CBT-AD
In addition to the ETAU content, the 11-session treatment modules, each lasting approximately 50 min, included (1) introducing the patient to the nature of CBT and motivational interviewing for behavior change (≈one session); (2) increasing pleasurable activities and mood monitoring (≈one session); (3) thought monitoring and cognitive restructuring (i.e., adaptive thinking; ≈five sessions); (4) problem-solving as a skill to aid in decision-making processes, particularly those related to HIV self-care (≈two sessions); and (5) relaxation training (≈two sessions). The therapist and participant were able to, however, structure the number of sessions spent on each module to meet the participants' individual needs. For all modules, participants were encouraged to apply these skills generally (i.e., via the use of home practice), but they were linked to HIV-care whenever possible. For additional details please see the published treatment manuals (Safren et al. 2007a, b) .
ISP-AD
The comparison condition included information with supportive psychotherapy, also in addition to the ETAU content described above. The 11 session ISP-AD manualized intervention developed by our group, with each session lasting up to 60 min, included first reviewing the patients' medication adherence, supportive psychotherapy to build self-esteem and enhance adaptive coping using strategies such as normalization, containment and encouragement. Informational topics also included nutrition, sleep, and depression in the context of HIV, as well as topics related to managing HIV such as an overview of HIV, managing HIV medication side effects, and the impact of risky behaviors, such as drug use, on adherence.
Participants
HIV-positive adults with a clinical diagnosis of depression (N = 240) were randomized at a 2:2:1 ratio to three groups (CBT-AD = 94; ISP-AD = 97; ETAU = 49). At baseline, the MINI (Sheehan et al. 1998 ) was used to assess psychiatric diagnoses. All depression assessments were conducted by a study assessor (Masters or Doctoral-level psychologist, clinical social worker) trained via audio-tape supervision in the assessment protocols. An independent assessor, blinded to treatment condition, conducted the interviewer-administered assessments of depression (Montgomery and Asberg 1979) at the 4-, 8-, and 12-month outcome assessments. Participants' demographic characteristics are presented in Table 1 .
Measures
Automatic Thoughts
The Automatic Thoughts Questionnaire (ATQ-30; Harrell and Ryon 1983) is a widely used measure with evidence for validity (Harrell and Ryon 1983; Kazdin 1990) , and thoroughly examined for reliability, construct validity, sensitivity and specificity (Hill et al. 1989; Ingram et al. 1995) . It has also has been used and recommended for use in PLWHA (McIntosh et al. 2013; Pomeroy et al. 2000; Valente 2003 ). Participants answer items on a 6-point Likert scale. Items assess for automatic thoughts and include statements such as, "I'm worthless," "I'm so disappointed in myself," and "I feel so helpless."
Depression
The interviewer-administered MADRS, a semi-structured clinical interview, (Montgomery and Asberg 1979) has been shown to be a valid and reliable measure in PLWHA (Labbe et al. 2015) . The MADRS was used to assess for depressive symptoms at baseline, and months 4, 8, and 12. Ratings were supervised via a selection of audio reviews by a staff psychologist also blind to treatment condition on a weekly basis. All depression assessments were conducted by a study assessor (Masters or Doctoral-level psychologist, clinical social worker) trained via audio-tape supervision in the assessment protocols. The measure assesses for the clinical symptoms of depression, including apparent sadness, reported sadness, reduced sleep, and changes in appetite, using broadly phrased questions about symptoms to more precise ones which allow for a rating of severity.
Data Analysis
We used a cross-lagged panel analysis to examine temporality and causality between ATs and depression across four time points (see Fig. 1 ), the best technique for determining the nature of the relation between two variables (Berrington et al. 2006) . Cross-lagged structural equation models address questions of causal ordering with longitudinal data. An advantage of this type of model is that it is estimated in one step, rather than a series of separate regressions, yielding a global likelihood model and all the tests and indices of model fit that are standard. AMOS version 22 was used to test the cross-lagged panel models.
Additionally, to further investigate this model across conditions, we ran autoregressive cross-lagged panel models for the CBT-AD and ISP groups separately. Unfortunately, sample size was insufficient to examine ETAU (Preacher and Coffman 2006) due to the 2:2:1 randomization into CBT-AD, ISP, and ETAU groups, respectively. 2:2:1 randomization was used to limit cost, patient burden, and yielded sufficient power to compare the experimental condition (CBT-AD) to the two control groups in the larger parent study.
Power
Using a well-supported tool, R, for establishing power, we calculated necessary sample size to power our analyses at 0.80 with significance set to 0.05 (Preacher and Coffman 2006) . Ns of 94 and 97 for the CBT-AD and ISP-AD groups were determined to be adequate to detect change, though the N of 49 for ETAU did not power the model well enough as a stand-alone model, according to accepted standards for cross-lagged panel analysis (Preacher and Coffman 2006) .
Results
Descriptives
The ATQ and MADRS both demonstrated normality. Table 2 ). These analyses did not include control variables as covariates; control variables decrease variance, limit power, and are not conceptually related to the questions asked. However, to address potential concerns that potential control (demographic) variables may be related to the outcome variables, we ran a series of regression analyses looking at age (age mean = 47.4, age SD = 8.4, age min = 22; age max = 66; B = −0.054, p = 0.428) and automatic thoughts (B = 0.171, p = 0.014) and their interaction (B = 0.102, p = 0.322) predicting depression, and conversely, age (B = −0.103, p = 0.065) and depression (B = 0.581, p < 0.001) and their interaction (B = −0.098, p = 0.053) predicting automatic thoughts, and there was not a significant interaction in these analyses.
Missing Data
There were 23 instances of missing data. According to missing value analysis in SPSS, these values appeared to be missing at random. This missing data was accounted for by REML in AMOS.
Cross-lagged Panel Analysis
The model including all three groups demonstrated that decreases in ATs were followed by decreases in depression (β= 0.113, p = 0.048; β=0.122, p = 0.044; β=0.172, p = 0.003), but decreases in depression were not followed by decreases in ATs (β= 0.097, p = 0.123; β=−0.011, p = 0.817; β=−0.036, p = 0.427; Fig. 2 ).
In the CBT-AD group, decreases in ATs predicted decreases in depression (β= 0.073, p = 0.019; β=0.713, p = 0.085; β=0.397, p = < 0.001), and decreases in depression predicted decreases in ATs (β= 0.125, p = < 0.001; β =0.070, p = 0.002; β=0.047, p = 0.026; Fig. 3) .
However, in the ISP group, while depression and ATs both significantly influenced each other, not all relations were in the direction expected. In the ISP group, ATs demonstrated a positive relation with depression between baseline to month 4 and month 4 to month 8 (β= 0.202, p < 0.001; β=0.109, p < 0.001), but not month 8 to month 12 (β=−0.116, p = 0.891). Additionally, there were negative relations between depression predicting ATs at month 4 to month 8 and month 8 to month 12 (β=−0.046, p = 0.049; β=−0.039, p = 0.043; See Fig. 4) . The relation between depression to ATs at baseline to month 4 was not statistically significant (β= 0.002, p = 0.945).
Discussion
These findings explicate the temporal nature of the relation between ATs and depression in PLWHA and depression, which has previously not been explored. The temporal effect on depression from decreases in ATs provides evidence for cognitive interventions to decrease depression in PLWHA. These findings also contribute to explaining the mechanisms through which cognitive behavioral therapies, such as CBT-AD, might work towards decreasing depression in a way that may provide long term benefits, a gap in the literature that has been identified in previous research (Forsyth et al. 2010; Furlong and Oei 2002) .
The overall model including all three groups showed that decreases in ATs were followed by decreases in depression, but decreases in depression were not followed by decreases in ATs. This model may be representative of a natural pattern among PLWHA in which ATs act on depression, though depression does not increase ATs. This pattern may suggest that, among PLWHA with depression, it continues to be a valid approach to focus our interventions on decreasing ATs. However, this model must be interpreted with caution, in light of the different patterns of relationships between the groups. More research is needed. The pattern changes, however, when examining only individuals in the CBT-AD intervention, such that decreases in ATs were followed by decreases in depression, and decreases in depression were followed by decreases in ATs. Since CBT-AD works in part by specifically addressing ATs (Forsyth et al. 2010; Moorey 2010) , it may be possible that this change in pattern from the general relation to the CBT-AD only group is related to the fact that CBT-AD specifically addresses ATs. This may in turn create a sort of positive feedback loop, such that in those who receive CBT-AD, as ATs decrease, depression decreases (as in the overall group), but also as depression decreases, ATs decrease as well because CBT-AD has linked depression and ATs for the patients, and a goal of CBT-AD for depression is to break this perpetuating cycle (Moorey 2010) . Because ATs and depression are linked together through psychoeducation for the CBT-AD group, a comparatively powerful symptom reduction loop is created, such that decreases in ATs lead to decreased depression, and decreases in depression lead to decreased ATs.
However, since ISP-AD does not directly address ATs, the temporal relation between changes in depression and changes in ATs is not as straightforward. In the ISP-AD group, while depression and ATs both significantly influenced each other, not all relations were in the direction expected, and some relations were not statistically significant. Specifically, decreases in depression predicted increases in ATs between 4 months to 8 months and 8 months to 12 months, and there were no statistically significant relations between baseline depression to month 4 ATs or month 4 ATs and month 8 depressive symptoms. Therefore, in the ISP-AD intervention, despite supportive psychotherapy for depression, ATs may be either remaining or increasing, and as a result, "leaving behind" a cognitive vulnerability factor. If true, the CBT-AD intervention that specifically focuses on ATs may be superior in the longer term.
There are several limitations to note. All of the sites were medical centers in the Northeast, with predominantly male participants, limiting generalizability. Treatments were also delivered under the supervision of PhD-level therapists with extensive knowledge of the intervention. This may limit the exportability of the treatment. It is possible that participants responded differently to the ATQ because they were specifically taught about ATs during the CBT-AD group. Additionally, it is important to note that the model of all participants that include all three study arms is confounded by the presence of a treatment intervention in two out of three groups, and therefore may not be representative of the general population's pattern of temporality between ATs and depressive symptoms.
Future research should focus on replicability. Additional measurement points may be helpful in further discriminating time-based effects and specificity of these models. Also, empirically testing as to whether this pattern of decreasing ATs and depressive symptoms are, in turn, related to other important outcomes in PLWHA, such as adherence, might be informative. Additionally, to more clearly identify the mechanism by which the CBT-AD intervention is working, a components analyses study would be useful. Also, collecting data from a larger treatment as usual sample could compare the intervention groups to a more naturally occurring pattern of relations between ATs and depressive symptoms in PLWHA. The interaction between age and depression may be important in terms of its relation to outcome automatic thoughts, although not powered to do so in the present study, this interaction may be important to measure and test in a larger sample.
These findings contribute to explaining the mechanism by which cognitive behavioral therapies, or CBT-AD in particular, might work towards decreasing depression in a way that may provide long term benefits. More research Fig. 4 ISP-AD 
